Mindbio Therapeutics

LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood Issues

MindBio Phase 2 LSD-Microdosing Clinical Trial In Patients With Major Depressive Disorder Begins Pre-Screening Participants

Psychedelics Investment Holder Blackhawk Growth Hosts Meeting For Potential Subsidiary Spin-Out

MindBio Phase 2 LSD-Microdosing Clinical Trial In Patients With Major Depressive Disorder Begins Pre-Screening Participants

Psychedelics Investment Holder Blackhawk Growth Hosts Meeting For Potential Subsidiary Spin-Out

LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress

Recap: Blackhawk Growth Fund's Most Recent Business Highlights, From Retail Sales To Phase 2 Clinical Trials

LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress

Recap: Blackhawk Growth Fund's Most Recent Business Highlights, From Retail Sales To Phase 2 Clinical Trials

New Zealand Government Grants $650K For LSD Microdosing Trials

The World's Largest Microdosing Clinical Trial Has Been Completed, Here Are The Results

Mindbio Therapeutics Recent News